The goal of this study is to test a new way to diagnose and track treatment of spine infections caused by the bacteria Staphylococcus aureus.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The percentage of Staphylococcus aureus spine implant associated infections correctly identified by "medium enriched for newly synthesized antibodies" (MENSA)
Timeframe: Baseline
Change "Medium enriched for newly synthesized antibodies" (MENSA) titers in the post-operative period
Timeframe: 2 weeks, 6 weeks, 3 months, 6 months, 1 year and 2 years post-surgery
"Medium enriched for newly synthesized antibodies" (MENSA) titers in spine implant infections compared to S. aureus infections of other orthopedic site infections.
Timeframe: Baseline